APA (7th ed.) Citation

Gu, J., Han, Z., Wang, C., & Zhang, J. (2025). The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic. Cardiovascular Drugs and Therapy, 39(3), 573-581. https://doi.org/10.1007/s10557-024-07570-4

Chicago Style (17th ed.) Citation

Gu, Jun, Zhi-Hua Han, Chang-qian Wang, and Jun-feng Zhang. "The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 Amid the Omicron Wave of the Pandemic." Cardiovascular Drugs and Therapy 39, no. 3 (2025): 573-581. https://doi.org/10.1007/s10557-024-07570-4.

MLA (9th ed.) Citation

Gu, Jun, et al. "The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 Amid the Omicron Wave of the Pandemic." Cardiovascular Drugs and Therapy, vol. 39, no. 3, 2025, pp. 573-581, https://doi.org/10.1007/s10557-024-07570-4.